Pivotal Study to Evaluate Efficacy and Safety of SP5M001 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

October 25, 2022

Study Completion Date

October 25, 2022

Conditions
Osteoarthritis Thumb
Interventions
DRUG

SP5M001 inj

pre-filled syringe

DRUG

Synovian inj

pre-filled syringe

Trial Locations (14)

Unknown

Yeungnam University Medical Center, Daegu

Cheonam National University Hwasun Hospital, Hwasun

Gachon University Gil Medical Center, Incheon

Jeonbuk National University Hospital, Jeonju

Chungnam National University Hospital, Sejong

Seoul National University Bundang Hospital, Seongnam-si

Asan Medical Center, Seoul

Chung-ang University Hospital, Seoul

Kyung Hee University Hospital at Gangdong, Seoul

Kyunghee University Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Soon Chun Hyang University Hospital Seoul, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY